Cancer Cachexia Market Size, Share, Trends, Growth 2032

Cancer Cachexia Industry Prospective:

The global cancer cachexia market size was evaluated at $3 billion in 2023 and is slated to hit $4 billion by the end of 2032 with a CAGR of nearly 5.2% between 2024 and 2032.

Request Free Sample

Cancer Cachexia Market: Overview

Cancer cachexia is a multifactorial syndrome leading to notable weight loss, body fat loss, anemia, and muscle mass loss in subjects. Individuals affected by cancer cachexia suffer from appetite loss, inflammation, fatigue, and weakness. Reportedly, this cancer cannot be cured but various kinds of therapies such as medicines, physical exercise, counseling, and nutritive diet can effectively manage the symptoms and enhance the life quality of patients.

Key Insights

• As per the analysis shared by our research analyst, the global cancer cachexia market is projected to expand annually at the annual growth rate of around 5.2% over the forecast timespan (2024-2032)
• In terms of revenue, the global cancer cachexia market size was evaluated at nearly $3 billion in 2023 and is expected to reach $4 billion by 2032.
• The global cancer cachexia market is anticipated to grow rapidly over the forecast timeline owing to an increase in cancer cases across the globe and the elderly population prone to the disease.
• In terms of product type, the combination therapies segment is slated to register the highest CAGR over the forecast period.
• Based on mechanism of action, the appetite stimulants segment is predicted to contribute majorly towards segmental space in the upcoming years.
• Based on distribution channel, the hospital pharmacies segment is likely to lead the global market growth in the ensuing years.
• Region-wise, the Asia-Pacific cancer cachexia industry is projected to register the fastest CAGR during the assessment timespan.

Cancer Cachexia Market: Growth Factors

A rise in the incidence of cancer to foster the global market trends over 2024-2032

An increase in cancer cases across the globe and the elderly population prone to the disease can propel the global cancer cachexia market growth. Breakthroughs in the modes of treating cancer with the launch of new drug therapies can expedite market trends across the globe. In addition, a rise in healthcare expenditure and advancements in diagnostics tools will leverage the global market expansion in the years ahead.

According to the National Institutes of Health, cachexia affects about 50% to 80% of persons suffering from cancer and is responsible for about 20% of deaths due to cancer. For the record, the death of an individual occurs when there is weight loss of more than 30% to 40%. As per the data estimates, in 2014, over 5,00,000 patients suffered from cancer cachexia, and in Europe, about 8,00,000 patients were affected due to it in 2013.

Cancer Cachexia Market: Restraints

Late diagnosis of cancer cachexia can retard the global industry expansion

Lack of effectiveness of targeted therapies and lack of clinical evidence for effective interventions of drugs on cancer cachexia can restrict the global cancer cachexia industry expansion. Furthermore, late diagnosis of cancer cachexia makes it difficult for physicians to opt for targeted cancer treatments, and this can retard the global industry growth.

Cancer Cachexia Market: Opportunities

Introduction of new types of personalized drugs can create new growth facades for the global market

Launch of new kinds of precision medicines and the application of combined drug therapies for treating cancer cachexia will create new growth avenues for the global cancer cachexia market. Surging awareness about the disease among healthcare service providers is projected to impel the expansion of the market across the globe.

Cancer Cachexia Market: Challenges

Economic upheavals can decimate the global industry surge in the ensuing years

Less availability of treatment alternatives and huge costs of cancer treatment can challenge the expansion of the global cancer cachexia industry. Moreover, side effects caused due to drug therapies on the subjects can deter the growth of the industry across the globe. Economic disruptions will further decimate the global industry expansion.

Cancer Cachexia Market: Segmentation

The global cancer cachexia market is divided into product type, mechanism of action, distribution channel, and region.                                             

In terms of product type, the cancer cachexia market across the globe is segmented into progestogens, combination therapies, and corticosteroids segments. Apparently, the combination therapies segment, which gathered nearly 60% of the global market revenue in 2023, is expected to record the fastest CAGR in the coming eight years, owing to the surging popularity of multimodal therapies among people suffering from cancer cachexia.

Additionally, a combination of various drugs targeting the disease can help reduce inflammation, stimulate appetite, and preserve muscles.    

Based on mechanism of action, the global cancer cachexia industry is divided into appetite stimulants and weight loss stabilizers segments. Apparently, the appetite stimulants segment, which led the global industry size in 2023, is set to contribute lucratively towards the segmental expansion in the analysis timespan. This can be due to a rise in the demand for the product by patients experiencing appetite and weight loss.

Reportedly, this product improves food consumption and helps the patient in gaining the required proportion of weight. This, in turn, will prop up the segmental surge in the ensuing years.

On the basis of distribution channel, the global cancer cachexia market is bifurcated into hospital pharmacies, online pharmacies, and retail pharmacies segments. Moreover, the hospital pharmacies segment, which led the global market share in 2023, is likely to lead the global market growth in the forecast timeframe.

The segmental surge in the coming eight years can be due to a rise in the occurrence of cancer patients requiring treatment in hospitals & special care in hospital settings. Reportedly, hospital pharmacies are well-equipped and can effectively handle complicated treatment regimens along with providing quick medicine access to patients.

Cancer Cachexia Market: Report Scope

Cancer Cachexia Market: Regional Insights

North America is likely to maintain leading status in the global market over the assessment period

North America, which accounted for approximately half of the global cancer cachexia market size in 2023, is predicted to retain its leading position in the global market in the following years.

Furthermore, the regional market expansion in the coming decade can be a result of a rise in the number of cancer patients in countries such as the U.S. Moreover, the availability of numerous healthcare facilities in the region and the presence of robust regulatory networking will proliferate the size of the regional market.  

The Asia-Pacific cancer cachexia industry is expected to register the fastest compound growth rate yearly in the forecast timeframe. The elevation of the industry in the Asia-Pacific region can be a result of the rising elderly population susceptible to cancer.

Moreover, supportive government initiatives, along with the availability of strong healthcare infrastructure, will promote industry growth in the region. Presence of key players in countries such as India and China will drive the expansion of the regional industry progression in the years ahead.

Cancer Cachexia Market: Competitive Space

The global cancer cachexia market profiles key players such as :

• GTx Inc.
• Aveo Oncology
• Aphios Corporation
• Merck & Co. Inc.
• Pfizer Inc.
• Novartis AG
• Fresenius Kabi
• Helsinn Group
• Bristol-Myers Squibb Company
• Aeterna Zentaris Inc.
• NGM Biopharmaceuticals
• Cannabics Pharmaceuticals Inc.
• Alder BioPharmaceuticals Inc.
• Actimed Therapeutics
• Eli Lilly and Company
• XBiotech Inc.
• Tetra Bio-Pharma.

The global cancer cachexia market is segmented as follows:

By Product Type

• Progestogens
•  Combination Therapies
• Corticosteroids

By Mechanism of Action

• Appetite Stimulants
• Weight Loss Stabilizers

By Distribution Channel

• Online Pharmacies
• Hospital Pharmacies
• Retail Pharmacies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa